Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
In Nordic countries 30-day mortality rate is half that estimated with EuroSCORE II in high-risk adult patients given aprotinin and undergoing mainly complex cardiac procedures
2
Zitationen
11
Autoren
2024
Jahr
Abstract
NAPaR data from Nordic countries suggest a favourable safety profile of aprotinin in adult cardiac surgery.
Ähnliche Arbeiten
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 5.207 Zit.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 · 3.243 Zit.
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
2015 · 2.440 Zit.
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
2020 · 2.424 Zit.
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 2.045 Zit.
Autoren
Institutionen
- Karolinska Institutet(SE)
- Oulu University Hospital(FI)
- University of Oulu(FI)
- Kuopio University Hospital(FI)
- Turku University Hospital(FI)
- University Hospital of Umeå(SE)
- St Olav's University Hospital(NO)
- Örebro University Hospital(SE)
- Tampere University Hospital(FI)
- Tampere University(FI)
- Skåne University Hospital(SE)
- Helsinki University Hospital(FI)